Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

References for PMC Articles for PubMed (Select 22460332)

1.

Evidence for ordering of Alzheimer disease biomarkers.

Jack CR Jr, Vemuri P, Wiste HJ, Weigand SD, Aisen PS, Trojanowski JQ, Shaw LM, Bernstein MA, Petersen RC, Weiner MW, Knopman DS; Alzheimer's Disease Neuroimaging Initiative.

Arch Neurol. 2011 Dec;68(12):1526-35. doi: 10.1001/archneurol.2011.183. Epub 2011 Aug 8.

2.

Structural imaging in early pre-states of dementia.

Smith CD.

Biochim Biophys Acta. 2012 Mar;1822(3):317-24. doi: 10.1016/j.bbadis.2011.07.002. Epub 2011 Jul 14. Review.

3.

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH.

Alzheimers Dement. 2011 May;7(3):280-92. doi: 10.1016/j.jalz.2011.03.003. Epub 2011 Apr 21.

4.

Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults.

Dickerson BC, Stoub TR, Shah RC, Sperling RA, Killiany RJ, Albert MS, Hyman BT, Blacker D, Detoledo-Morrell L.

Neurology. 2011 Apr 19;76(16):1395-402. doi: 10.1212/WNL.0b013e3182166e96. Epub 2011 Apr 13.

5.

Identifying cognitively healthy elderly individuals with subsequent memory decline by using automated MR temporoparietal volumes.

Chiang GC, Insel PS, Tosun D, Schuff N, Truran-Sacrey D, Raptentsetsang S, Jack CR Jr, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Radiology. 2011 Jun;259(3):844-51. doi: 10.1148/radiol.11101637. Epub 2011 Apr 5.

6.

Amyloid-╬▓ associated cortical thinning in clinically normal elderly.

Becker JA, Hedden T, Carmasin J, Maye J, Rentz DM, Putcha D, Fischl B, Greve DN, Marshall GA, Salloway S, Marks D, Buckner RL, Sperling RA, Johnson KA.

Ann Neurol. 2011 Jun;69(6):1032-42. doi: 10.1002/ana.22333. Epub 2011 Mar 17.

7.

Adding delayed recall to the Alzheimer Disease Assessment Scale is useful in studies of mild cognitive impairment but not Alzheimer disease.

Sano M, Raman R, Emond J, Thomas RG, Petersen R, Schneider LS, Aisen PS.

Alzheimer Dis Assoc Disord. 2011 Apr-Jun;25(2):122-7. doi: 10.1097/WAD.0b013e3181f883b7.

8.

Six-month atrophy in MTL structures is associated with subsequent memory decline in elderly controls.

Murphy EA, Holland D, Donohue M, McEvoy LK, Hagler DJ Jr, Dale AM, Brewer JB; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2010 Dec;53(4):1310-7. doi: 10.1016/j.neuroimage.2010.07.016. Epub 2010 Jul 13.

9.

A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline.

den Heijer T, van der Lijn F, Koudstaal PJ, Hofman A, van der Lugt A, Krestin GP, Niessen WJ, Breteler MM.

Brain. 2010 Apr;133(Pt 4):1163-72. doi: 10.1093/brain/awq048.

10.

Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia.

Bourgeat P, Ch├ętelat G, Villemagne VL, Fripp J, Raniga P, Pike K, Acosta O, Szoeke C, Ourselin S, Ames D, Ellis KA, Martins RN, Masters CL, Rowe CC, Salvado O; AIBL Research Group.

Neurology. 2010 Jan 12;74(2):121-7. doi: 10.1212/WNL.0b013e3181c918b5.

PMID:
20065247
11.

Neuroimaging through the course of Alzheimer's disease.

Smith CD.

J Alzheimers Dis. 2010;19(1):273-90. doi: 10.3233/JAD-2010-1217. Review.

PMID:
20061644
12.
13.

Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal.

Apostolova LG, Mosconi L, Thompson PM, Green AE, Hwang KS, Ramirez A, Mistur R, Tsui WH, de Leon MJ.

Neurobiol Aging. 2010 Jul;31(7):1077-88. doi: 10.1016/j.neurobiolaging.2008.08.008. Epub 2008 Sep 24.

14.

Evidence that volume of anterior medial temporal lobe is reduced in seniors destined for mild cognitive impairment.

Martin SB, Smith CD, Collins HR, Schmitt FA, Gold BT.

Neurobiol Aging. 2010 Jul;31(7):1099-106. doi: 10.1016/j.neurobiolaging.2008.08.010. Epub 2008 Sep 21.

15.

Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects.

Hua X, Leow AD, Parikshak N, Lee S, Chiang MC, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2008 Nov 15;43(3):458-69. doi: 10.1016/j.neuroimage.2008.07.013. Epub 2008 Jul 22.

16.

A simple procedure to improve FMRIb Software Library Brain Extraction Tool performance.

Fagiolo G, Waldman A, Hajnal JV.

Br J Radiol. 2008 Mar;81(963):250-1. doi: 10.1259/bjr/12956156. Epub 2008 Jan 7.

PMID:
18180266
17.

Trajectories of brain loss in aging and the development of cognitive impairment.

Carlson NE, Moore MM, Dame A, Howieson D, Silbert LC, Quinn JF, Kaye JA.

Neurology. 2008 Mar 11;70(11):828-33. Epub 2007 Nov 28.

PMID:
18046010
18.

Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack CR, Jagust W, Trojanowski JQ, Toga AW, Beckett L.

Alzheimers Dement. 2005 Jul;1(1):55-66.

19.

Brain structural alterations before mild cognitive impairment.

Smith CD, Chebrolu H, Wekstein DR, Schmitt FA, Jicha GA, Cooper G, Markesbery WR.

Neurology. 2007 Apr 17;68(16):1268-73.

PMID:
17438217
20.

Brain imaging evidence of preclinical Alzheimer's disease in normal aging.

Jagust W, Gitcho A, Sun F, Kuczynski B, Mungas D, Haan M.

Ann Neurol. 2006 Apr;59(4):673-81.

PMID:
16470518
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk